A PRIMATE MODEL OF UREAPLASMA-UREALYTICUM INFECTION IN THE PREMATURE-INFANT WITH HYALINE-MEMBRANE DISEASE

被引:33
|
作者
WALSH, WF
BUTLER, J
COALSON, J
HENSLEY, D
CASSELL, GH
DELEMOS, RA
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284
[2] SW FDN BIOMED RES,SAN ANTONIO,TX 78284
[3] WILFORD HALL USAF MED CTR,DIV NEONATOL,LACKLAND AFB,TX 78236
[4] WILFORD HALL USAF MED CTR,CLIN INVEST FACIL,LACKLAND AFB,TX 78236
[5] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
关键词
D O I
10.1093/clinids/17.Supplement_1.S158
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cultures positive for Ureaplasma urealyticum in babies weighing <1000 g have been associated with both chronic lung disease (CLD) and death, but no definite causality has been established. To further investigate the role of the organism in CLD, we colonized premature baboons with U. urealyticum and compared resulting pathology with that in uninoculated control animals. Using an established model of prematurity, the 140-day-gestation baboon, three animals were colonized with U. urealyticum via endotracheal tube. All had hyaline membrane disease, indistinguishable from disease in human infants, and U. urealyticum infection. Samples obtained from nasopharynx, trachea, pleural fluid, and, at necropsy, lung tissue produced positive cultures. Culture of blood from one animal yielded U. urealyticum. On pathologic examination, after 6 days of ventilation, all three of the infected animals had the specific pathologic finding of bronchiolitis with epithelial ulceration not seen in four uninfected control animals. Thus, U. urealyticum is capable of causing a pathologically recognizable pulmonary lesion in premature primates with hyaline membrane disease.
引用
收藏
页码:S158 / S162
页数:5
相关论文
共 50 条
  • [31] QUANTITATIVE MODEL OF HYALINE-MEMBRANE DISEASE (HMD) COURSE
    GREEN, R
    ROJAS, J
    LINDSTROM, D
    NIERMEYER, S
    OLSSON, T
    STAHLMAN, M
    COTTON, R
    PEDIATRIC RESEARCH, 1979, 13 (04) : 495 - 495
  • [32] NEW EXPERIMENTAL MODEL FOR HYALINE-MEMBRANE DISEASE OF NEWBORN
    BALIS, JU
    SHELLEY, S
    PAGAST, P
    MCKEEVER, L
    LABORATORY INVESTIGATION, 1972, 26 (04) : 469 - &
  • [33] NEONATAL BABOON MODEL FOR STUDIES IN HYALINE-MEMBRANE DISEASE
    ESCOBEDO, MB
    ROBOTHAM, JL
    HILLIARD, JL
    SMITH, F
    MEREDITH, K
    WALSH, W
    JOHNSON, D
    COALSON, J
    KUEHL, T
    CLINICAL RESEARCH, 1980, 28 (05): : A871 - A871
  • [34] ANTENATAL INFECTION - ADEQUATE PROTECTION AGAINST HYALINE-MEMBRANE DISEASE
    DIMMICK, J
    MAHMOOD, K
    ALTSHULER, G
    OBSTETRICS AND GYNECOLOGY, 1976, 47 (01): : 56 - 62
  • [35] HYALINE-MEMBRANE DISEASE - EFFECT OF SURFACTANT PROPHYLAXIS ON LUNG MORPHOLOGY IN PREMATURE PRIMATES
    CUTZ, E
    ENHORNING, G
    ROBERTSON, B
    SHERWOOD, WG
    HILL, DE
    AMERICAN JOURNAL OF PATHOLOGY, 1978, 92 (03): : 581 - 594
  • [36] EVALUATION OF COMPLEMENT ACTIVATION IN PREMATURE NEWBORN-INFANTS WITH HYALINE-MEMBRANE DISEASE
    CAT, R
    DEMESSIAS, IT
    RESENER, TD
    KIRSCHFINK, M
    EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (03) : 205 - 208
  • [37] TOXIC EFFECTS ASSOCIATED WITH THE ADMINISTRATION OF DEFEROXAMINE IN THE PREMATURE BABOON WITH HYALINE-MEMBRANE DISEASE
    DELEMOS, RA
    ROBERTS, RJ
    COALSON, JJ
    DELEMOS, JA
    NULL, DM
    GERSTMANN, DR
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (08): : 915 - 919
  • [38] EFFECT OF SURFACTANT THERAPY ON DUCTAL SHUNTING IN PREMATURE BABOONS WITH HYALINE-MEMBRANE DISEASE
    MCCURNIN, D
    SEIDNER, S
    CLINICAL RESEARCH, 1992, 40 (04): : A825 - A825
  • [39] INDOMETHACINE AND SURGICAL LIGATION OF PDA IN SURFACTANT TREATED PREMATURE BABOON HYALINE-MEMBRANE DISEASE (HMD) MODEL
    SHIMADA, S
    JAIN, L
    GHAL, V
    VIDYASAGAR, D
    BHAT, R
    RAJU, TNK
    CLINICAL RESEARCH, 1987, 35 (06): : A912 - A912
  • [40] QUANTITATIVE MODEL FOR HYALINE-MEMBRANE DISEASE (HMD) COURSE AND OUTCOME
    ROJAS, J
    GREEN, R
    LINDSTROM, D
    FANNON, L
    OLSSON, T
    COTTON, R
    CLINICAL RESEARCH, 1979, 27 (05): : A822 - A822